Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet

The drug is used to treat psychotic disorders such as schizophrenia

FPJ Web DeskUpdated: Tuesday, January 10, 2023, 04:01 PM IST
article-image
Ajanta Pharma gets USFDA nod for Fluphenazine Hydrochloride tablet | Image: Ajanta Pharma (Representative)

Ajanta Pharma Ltd has received an approval from the US Food and Drug Administration (USFDA) for Fluphenazine Hydrochloride tablet, as per an exchange filing.

The dosage is in 1 mg, 2.5 mg, 5 mg and 10 mg strengths, according to an update on the drug regulator's website.

The drug is used to treat psychotic disorders such as schizophrenia.

RECENT STORIES

Mercedes-Benz India To Hike Prices By Up To 1.5% In September Amid Rupee-Euro Fluctuations

Mercedes-Benz India To Hike Prices By Up To 1.5% In September Amid Rupee-Euro Fluctuations

Marico Aims To Double Revenue To ₹20,000 Crore By 2030, Eyes Growth Through Innovation And Digital...

Marico Aims To Double Revenue To ₹20,000 Crore By 2030, Eyes Growth Through Innovation And Digital...

Cipla To Enter India’s Weight Management Market, Strengthens CNS & AMR Focus

Cipla To Enter India’s Weight Management Market, Strengthens CNS & AMR Focus

NLC India In Final Talks With Russian PSU For Lithium Sourcing, Eyes Mali Mine Stake In Africa

NLC India In Final Talks With Russian PSU For Lithium Sourcing, Eyes Mali Mine Stake In Africa

India, US Inch Closer To Interim Trade Pact, Tariff Uncertainty Looms Amid Key Unresolved Issues

India, US Inch Closer To Interim Trade Pact, Tariff Uncertainty Looms Amid Key Unresolved Issues